{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:08:29Z","timestamp":1780322909590,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"INSERM poste d'accueil"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10637-018-0677-7","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T06:48:00Z","timestamp":1540536480000},"page":"1075-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-6945","authenticated-orcid":false,"given":"Paul","family":"Berveiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine A.","family":"Degrelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Selleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Guibourdenche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Evain-Brion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"677_CR1","unstructured":"Minino AM, Xu J, Kochanek KD, Tejada-Vera B (2009) Death in the United States, 2007. NCHS Data Brief 1-8"},{"key":"677_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683\u2013689","journal-title":"J Clin Oncol"},{"key":"677_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamaoncol.2015.2413","volume":"1","author":"S Loibl","year":"2015","unstructured":"Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C et al (2015) Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients. JAMA Oncol 1:1145\u20131153","journal-title":"JAMA Oncol"},{"key":"677_CR4","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","volume":"46","author":"F Amant","year":"2010","unstructured":"Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L et al (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46:3158\u20133168","journal-title":"Eur J Cancer"},{"key":"677_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/annonc\/mdm460","volume":"19","author":"O Mir","year":"2008","unstructured":"Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F (2008) Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 19:607\u2013613","journal-title":"Ann Oncol"},{"key":"677_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/annonc\/mdp517","volume":"21","author":"O Mir","year":"2010","unstructured":"Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21:425\u2013426","journal-title":"Ann Oncol"},{"key":"677_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000341820","volume":"83","author":"P Berveiller","year":"2012","unstructured":"Berveiller P, Mir O (2012) Taxanes during Pregnancy: Probably Safe, but Still to Be Optimized. Oncology 83:239\u2013240","journal-title":"Oncology"},{"key":"677_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/cbt.27632","volume":"15","author":"D Theile","year":"2014","unstructured":"Theile D, Gal Z, Warta R, Rigalli J, Lahrmann B, Grabe N, Herold-Mende C, Dyckhoff G, Weiss J (2014) Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma. Cancer Biol Ther 15:4","journal-title":"Cancer Biol Ther"},{"key":"677_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jconrel.2006.10.007","volume":"117","author":"EA Ho","year":"2007","unstructured":"Ho EA, Soo PL, Allen C, Piquette-Miller M (2007) Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. J Control Release : Off J Control Release Soc 117:20\u201327","journal-title":"J Control Release : Off J Control Release Soc"},{"key":"677_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X et al (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215\u2013236","journal-title":"Nat Rev Drug Discov"},{"key":"677_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","volume":"112","author":"I Cascorbi","year":"2006","unstructured":"Cascorbi I (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457\u2013473","journal-title":"Pharmacol Ther"},{"key":"677_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-59745-205-2_4","volume":"448","author":"TM Sissung","year":"2008","unstructured":"Sissung TM, Gardner ER, Gao R, Figg WD (2008) Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol 448:41\u201362","journal-title":"Methods Mol Biol"},{"key":"677_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2133\/dmpk.23.223","volume":"23","author":"K Maeda","year":"2008","unstructured":"Maeda K, Sugiyama Y (2008) Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet 23:223\u2013235","journal-title":"Drug Metab Pharmacokinet"},{"key":"677_CR14","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1128\/MCB.23.21.7902-7908.2003","volume":"23","author":"JW Jonker","year":"2003","unstructured":"Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH (2003) Deficiency in the organic cation transporters 1 and 2 (Oct1\/Oct2 [Slc22a1\/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23:7902\u20137908","journal-title":"Mol Cell Biol"},{"key":"677_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0959-8049(95)00130-B","volume":"31","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Mol CA, Wagenaar E, van Deemter L, Smit JJ, Borst P (1995) Multidrug resistance and the role of P-glycoprotein knockout mice. Eur J Cancer 31:1295\u20131298","journal-title":"Eur J Cancer"},{"key":"677_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","volume":"158","author":"K Vahakangas","year":"2009","unstructured":"Vahakangas K, Myllynen P (2009) Drug transporters in the human blood-placental barrier. Br J Pharmacol 158:665\u2013678","journal-title":"Br J Pharmacol"},{"key":"677_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","volume":"33","author":"M Iqbal","year":"2012","unstructured":"Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG (2012) Placental drug transporters and their role in fetal protection. Placenta 33:137\u2013142","journal-title":"Placenta"},{"key":"677_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","volume":"20","author":"F Staud","year":"2012","unstructured":"Staud F, Cerveny L, Ceckova M (2012) Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target 20:736\u2013763","journal-title":"J Drug Target"},{"key":"677_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2174\/138920111795470877","volume":"12","author":"T Eshkoli","year":"2011","unstructured":"Eshkoli T, Sheiner E, Ben-Zvi Z, Holcberg G (2011) Drug transport across the placenta. Curr Pharm Biotechnol 12:707\u2013714","journal-title":"Curr Pharm Biotechnol"},{"key":"677_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1124\/dmd.110.033571","volume":"38","author":"C Prouillac","year":"2010","unstructured":"Prouillac C, Lecoeur S (2010) The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 38:1623\u20131635","journal-title":"Drug Metab Dispos"},{"key":"677_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.lfs.2010.09.015","volume":"88","author":"V Ganapathy","year":"2011","unstructured":"Ganapathy V (2011) Drugs of abuse and human placenta. Life Sci 88:926\u2013930","journal-title":"Life Sci"},{"key":"677_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/138920111795164057","volume":"12","author":"Z Ni","year":"2011","unstructured":"Ni Z, Mao Q (2011) ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 12:674\u2013685","journal-title":"Curr Pharm Biotechnol"},{"key":"677_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.placenta.2014.11.001","volume":"36","author":"P Berveiller","year":"2015","unstructured":"Berveiller P, Degrelle SA, Segond N, Cohen H, Evain-Brion D, Gil S (2015) Drug transporter expression during in vitro differentiation of first-trimester and term human villous trophoblasts. Placenta 36:93\u201396","journal-title":"Placenta"},{"key":"677_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1210\/endo-118-4-1567","volume":"118","author":"HJ Kliman","year":"1986","unstructured":"Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567\u20131582","journal-title":"Endocrinology"},{"key":"677_CR25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/labinvest.3780334","volume":"81","author":"A Tarrade","year":"2001","unstructured":"Tarrade A, Lai Kuen R, Malassine A, Tricottet V, Blain P, Vidaud M, Evain-Brion D (2001) Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest 81:1199\u20131211","journal-title":"Lab Invest"},{"key":"677_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.placenta.2006.01.019","volume":"28","author":"K Handschuh","year":"2007","unstructured":"Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D et al (2007) Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. Placenta 28:175\u2013184","journal-title":"Placenta"},{"key":"677_CR27","doi-asserted-by":"publisher","first-page":"E950","DOI":"10.1152\/ajpendo.00087.2012","volume":"303","author":"M Cocquebert","year":"2012","unstructured":"Cocquebert M, Berndt S, Segond N, Guibourdenche J, Murthi P, Aldaz-Carroll L et al (2012) Comparative expression of hCG beta-genes in human trophoblast from early and late firsttrimester placentas. Am J Physiol Endocrinol Metab 303:E950\u2013E958","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"677_CR28","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1210\/endo.142.8.8329","volume":"142","author":"JL Frendo","year":"2001","unstructured":"Frendo JL, Therond P, Bird T, Massin N, Muller F, Guibourdenche J et al (2001) Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology 142:3638\u20133648","journal-title":"Endocrinology"},{"key":"677_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jcp.1041540115","volume":"154","author":"E Alsat","year":"1993","unstructured":"Alsat E, Haziza J, Evain-Brion D (1993) Increase in epidermal growth factor receptor and its messenger ribonucleic acid levels with differentiation of human trophoblast cells in culture. J Cell Physiol 154:122\u2013128","journal-title":"J Cell Physiol"},{"key":"677_CR30","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1242\/jcs.00648","volume":"116","author":"JL Frendo","year":"2003","unstructured":"Frendo JL, Cronier L, Bertin G, Guibourdenche J, Vidaud M, Evain-Brion D, Malassine A (2003) Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J Cell Sci 116:3413\u20133421","journal-title":"J Cell Sci"},{"key":"677_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2165\/00003088-199427040-00002","volume":"27","author":"DS Sonnichsen","year":"1994","unstructured":"Sonnichsen DS, Relling MV (1994) Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet 27:256\u2013269","journal-title":"Clin Pharmacokinet"},{"key":"677_CR32","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.ajog.2012.10.007","volume":"207","author":"P Berveiller","year":"2012","unstructured":"Berveiller P, Vinot C, Mir O, Broutin S, Deroussent A, Seck A, Camps S, Paci A, Gil S, Treluyer JM (2012) Comparative transplacental transfer of taxanes using the human perfused cotyledon placental model. Am J Obstet Gynecol 207:e511\u2013e514","journal-title":"Am J Obstet Gynecol"},{"key":"677_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1152\/ajpcell.00484.2008","volume":"298","author":"G Pidoux","year":"2010","unstructured":"Pidoux G, Gerbaud P, Gnidehou S, Grynberg M, Geneau G, Guibourdenche J, Carette D, Cronier L, Evain-Brion D, Malassine A et al (2010) ZO-1 is involved in trophoblastic cell differentiation in human placenta. Am J Physiol Cell Physiol 298:1517\u20131526","journal-title":"Am J Physiol Cell Physiol"},{"key":"677_CR34","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1210\/en.2007-0589","volume":"148","author":"G Pidoux","year":"2007","unstructured":"Pidoux G, Gerbaud P, Marpeau O, Guibourdenche J, Ferreira F, Badet J, Evain-Brion D, Frendo JL (2007) Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies. Endocrinology 148:5403\u20135413","journal-title":"Endocrinology"},{"key":"677_CR35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1242\/jcs.111.7.995","volume":"111","author":"G Keryer","year":"1998","unstructured":"Keryer G, Alsat E, Tasken K, Evain-Brion D (1998) Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J Cell Sci 111:995\u20131004","journal-title":"J Cell Sci"},{"key":"677_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1","volume":"168","author":"E Alsat","year":"1996","unstructured":"Alsat E, Wyplosz P, Malassine A, Guibourdenche J, Porquet D, Nessmann C, Evain-Brion D (1996) Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J Cell Physiol 168:346\u2013353","journal-title":"J Cell Physiol"},{"key":"677_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejogrb.2009.08.007","volume":"147","author":"L Gavard","year":"2009","unstructured":"Gavard L, Beghin D, Forestier F, Cayre Y, Peytavin G, Mandelbrot L, Farinotti R, Gil S (2009) Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir. Eur J Obstet Gynecol Reprod Biol 147:157\u2013160","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"677_CR38","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","volume":"114","author":"H Schneider","year":"1972","unstructured":"Schneider H, Panigel M, Dancis J (1972) Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114:822\u2013828","journal-title":"Am J Obstet Gynecol"},{"key":"677_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","volume":"30","author":"L Mathiesen","year":"2010","unstructured":"Mathiesen L, Mose T, Morck TJ, Nielsen JK, Nielsen LK, Maroun LL et al (2010) Quality assessment of a placental perfusion protocol. Reprod Toxicol 30:138\u2013146","journal-title":"Reprod Toxicol"},{"key":"677_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0005-2736(99)00171-6","volume":"1461","author":"R Abele","year":"1999","unstructured":"Abele R, Tampe R (1999) Function of the transport complex TAP in cellular immune recognition. Biochim Biophys Acta 1461:405\u2013419","journal-title":"Biochim Biophys Acta"},{"key":"677_CR41","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1096\/fj.08-121855","volume":"23","author":"E Procko","year":"2009","unstructured":"Procko E, O'Mara ML, Bennett WF, Tieleman DP, Gaudet R (2009) The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter. FASEB J 23:1287\u20131302","journal-title":"FASEB J"},{"key":"677_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0143-4004(05)80640-X","volume":"17","author":"KF Roby","year":"1996","unstructured":"Roby KF, Gershon D, Hunt JS (1996) Expression of the transporter for antigen processing-1 (Tap-1) Gene in subpopulations of human trophoblast cells. Placenta 17:27\u201332","journal-title":"Placenta"},{"key":"677_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0006-291X(02)00659-9","volume":"295","author":"A Piehler","year":"2002","unstructured":"Piehler A, Kaminski WE, Wenzel JJ, Langmann T, Schmitz G (2002) Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem Biophys Res Commun 295:408\u2013416","journal-title":"Biochem Biophys Res Commun"},{"key":"677_CR44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1755-148X.2009.00630.x","volume":"22","author":"KG Chen","year":"2009","unstructured":"Chen KG, Valencia JC, Gillet JP, Hearing VJ, Gottesman MM (2009) Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res 22:740\u2013749","journal-title":"Pigment Cell Melanoma Res"},{"key":"677_CR45","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-10-3623","volume":"71","author":"EA Hopper-Borge","year":"2011","unstructured":"Hopper-Borge EA, Churchill T, Paulose C, Nicolas E, Jacobs JD, Ngo O et al (2011) Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-\/-) mice. Cancer Res 71:3649\u20133657","journal-title":"Cancer Res"},{"key":"677_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2133\/dmpk.20.452","volume":"20","author":"M Nishimura","year":"2005","unstructured":"Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human ATPbinding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20:452\u2013477","journal-title":"Drug Metab Pharmacokinet"},{"key":"677_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-12-394316-3.00004-1","volume":"70","author":"B Doring","year":"2012","unstructured":"Doring B, Lutteke T, Geyer J, Petzinger E (2012) The SLC10 carrier family: transport functions and molecular structure. Curr Top Membr 70:105\u2013168","journal-title":"Curr Top Membr"},{"key":"677_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1124\/dmd.110.034470","volume":"38","author":"V Petrovic","year":"2010","unstructured":"Petrovic V, Piquette-Miller M (2010) Impact of polyinosinic\/polycytidylic acid on placental and hepatobiliary drug transporters in pregnant rats. Drug Metab Dispos 38:1760\u20131766","journal-title":"Drug Metab Dispos"},{"key":"677_CR49","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1124\/dmd.107.014852","volume":"35","author":"Q Wang","year":"2007","unstructured":"Wang Q, Morris ME (2007) The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells. Drug Metab Dispos 35:1393\u20131399","journal-title":"Drug Metab Dispos"},{"key":"677_CR50","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/jps.10246","volume":"91","author":"K Nagasawa","year":"2002","unstructured":"Nagasawa K, Nagai K, Sumitani Y, Moriya Y, Muraki Y, Takara K, Ohnishi N, Yokoyama T, Fujimoto S (2002) Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. J Pharm Sci 91:2605\u20132613","journal-title":"J Pharm Sci"},{"key":"677_CR51","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1074\/jbc.M007746200","volume":"276","author":"MW Ritzel","year":"2001","unstructured":"Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ et al (2001) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914\u20132927","journal-title":"J Biol Chem"},{"key":"677_CR52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/BF00374155","volume":"429","author":"LF Barros","year":"1995","unstructured":"Barros LF, Yudilevich DL, Jarvis SM, Beaumont N, Young JD, Baldwin SA (1995) Immunolocalisation of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms. Pflugers Arch 429:394\u2013399","journal-title":"Pflugers Arch"},{"key":"677_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1349-7006.2010.01837.x","volume":"102","author":"R Nishio","year":"2011","unstructured":"Nishio R, Tsuchiya H, Yasui T, Matsuura S, Kanki K, Kurimasa A, Hisatome I, Shiota G (2011) Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd). Cancer Sci 102:622\u2013629","journal-title":"Cancer Sci"},{"key":"677_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.placenta.2010.01.013","volume":"31","author":"LS Loubiere","year":"2010","unstructured":"Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, McCabe CJ, Franklyn JA, Kilby MD, Chan SY (2010) Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31:295\u2013304","journal-title":"Placenta"},{"key":"677_CR55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1042\/CS20150554","volume":"130","author":"FJ Rosario","year":"2016","unstructured":"Rosario FJ, Dimasuay KG, Kanai Y, Powell TL, Jansson T (2016) Regulation of amino acid transporter trafficking by mTORC1 in primary human trophoblast cells is mediated by the ubiquitin ligase Nedd4-2. Clin Sci 130:499\u2013512","journal-title":"Clin Sci"},{"key":"677_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/plac.2002.0879","volume":"24","author":"P Patel","year":"2003","unstructured":"Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, Williamson C (2003) Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C,OATP-D, OATPE and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 24:39\u201344","journal-title":"Placenta"},{"key":"677_CR57","doi-asserted-by":"publisher","first-page":"E390","DOI":"10.1152\/ajpendo.00257.2002","volume":"284","author":"B Ugele","year":"2003","unstructured":"Ugele B, St-Pierre MV, Pihusch M, Bahn A, Hantschmann P (2003) Characterization and identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol Metab 284:E390\u2013E398","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"677_CR58","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.2174\/092986708786848479","volume":"15","author":"T Furukawa","year":"2008","unstructured":"Furukawa T, Komatsu M, Ikeda R, Tsujikawa K, Akiyama S (2008) Copper transport systems are involved in multidrug resistance and drug transport. Curr Med Chem 15:3268\u20133278","journal-title":"Curr Med Chem"},{"key":"677_CR59","first-page":"6559","volume":"62","author":"K Katano","year":"2002","unstructured":"Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo YM, Rochdi M, Howell SB (2002) Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62:6559\u20136565","journal-title":"Cancer Res"},{"key":"677_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.placenta.2010.11.002","volume":"32","author":"B Hardman","year":"2011","unstructured":"Hardman B, Luff S, Ackland ML (2011) Differential intracellular localisation of the Menkes and Wilson copper transporting ATPases in the third trimester human placenta. Placenta 32:79\u201385","journal-title":"Placenta"},{"key":"677_CR61","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/hed.21559","volume":"33","author":"D Theile","year":"2011","unstructured":"Theile D, Ketabi-Kiyanvash N, Herold-Mende C, Dyckhoff G, Efferth T, Bertholet V, Haefeli WE, Weiss J (2011) Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck 33:959\u2013968","journal-title":"Head Neck"},{"key":"677_CR62","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.bcp.2005.03.030","volume":"69","author":"T Nanovskaya","year":"2005","unstructured":"Nanovskaya T, Nekhayeva I, Karunaratne N, Audus K, Hankins GD, Ahmed MS (2005) Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 69:1869\u20131878","journal-title":"Biochem Pharmacol"},{"key":"677_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1055\/s-2006-951301","volume":"23","author":"IA Nekhayeva","year":"2006","unstructured":"Nekhayeva IA, Nanovskaya TN, Hankins GD, Ahmed MS (2006) Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel. Am J Perinatol 23:423\u2013430","journal-title":"Am J Perinatol"},{"key":"677_CR64","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/IGC.0000000000000062","volume":"24","author":"F Amant","year":"2014","unstructured":"Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, Van Calsteren K, Han SN, Mir O, Fruscio R, Uzan C et al (2014) Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 24:394\u2013403","journal-title":"Int J Gynecol Cancer"},{"key":"677_CR65","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00280-009-1221-4","volume":"66","author":"S Harmsen","year":"2010","unstructured":"Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, Schellens JH (2010) PXRmediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinomaderived cell line. Cancer Chemother Pharmacol 66:765\u2013771","journal-title":"Cancer Chemother Pharmacol"},{"key":"677_CR66","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1471-2407-8-318","volume":"8","author":"SL Hembruff","year":"2008","unstructured":"Hembruff SL, Laberge ML, Villeneuve DJ, Guo B, Veitch Z, Cecchetto M, Parissenti AM (2008) Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance. BMC Cancer 8:318","journal-title":"BMC Cancer"},{"key":"677_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.placenta.2018.03.002","volume":"64","author":"M Verheecke","year":"2018","unstructured":"Verheecke M, Cortes Calabuig A, Finalet Ferreiro J, Brys V, Van Bree R, Verbist G et al (2018) Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction. Placenta 64:61\u201370","journal-title":"Placenta"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-018-0677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:35:05Z","timestamp":1678559705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-018-0677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1007\/s10637-018-0677-7","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"13 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Berveiller declares that he has no conflict of interest.Dr. Mir has acted as consultant for Astra-Zeeneca, Amgen, Bayer Healthcare, Blueprint Medicines, Bristol-Myers Squibb, Eli-Lilly, Incyte, Ipsen, Lundbeck, Novartis, Pfizer, PharmaMar, Roche, Servier and Vifor Pharma.Dr. Degrelle declares that she has no conflict of interest.Pr. Tsatsaris declares that he has no conflict of interest.Dr. Selleret declares that she has no conflict of interest.Pr. Guibourdenche declares that he has no conflict of interest.Dr. Evain-Brion declares that she has no conflict of interest.Dr. Fournier declares that he has no conflict of interest.Pr. Gil declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving our patients were in accordance with the ethical standards of the Local Ethic Committee (CPP, Paris Cochin, N\u00b018\u201305, France) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in our study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}